Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2023

Stockholders' Equity

Schedule of components of stock-based compensation included in net loss

	For the Years ended
	December 31,
	2023		2022
Employee stock options	$	1,929,665	$	2,782,694
Non-employee stock options		563,415		1,114,894
Employee stock awards		135,095		169,571
Non-employee stock awards		101		18,578
	$	2,628,276	$	4,085,737

Schedule of stock option valuation assumptions

	2022
Dividend yield	—	%
Expected volatility	100.85-105.09	%
Risk-free interest rate	1.95-3.61	%
Expected lives (years)	5.3-6.1	years

Schedule of stock option activity

		Weighted				Weighted
		Average		Aggregate		Average
		Exercise		Intrinsic		Remaining
	Shares	Price		Value		Contractual Life
Stock options outstanding at December 31, 2021	2,954,315	$	7.62	$	100,419
Granted	4,307,599		1.10
Exercised	(12,765)		1.30	$	—
Expired	(82,253)		10.20
Forfeited	(130,022)		4.44
Stock options outstanding at December 31, 2022	7,036,874	$	3.67	$	16,842
Expired	(198,478)		6.69
Forfeited	(399,465)		2.88
Stock options outstanding and expected to vest at December 31, 2023	6,438,931	$	3.63	$	9,052	8.0	Years
Stock options exercisable at December 31, 2023	4,601,719	$	4.52	$	9,052	7.7	Years

Schedule of restricted stock activity

		Weighted
		Average
	Shares	Fair Value
Restricted stock at December 31, 2021	370,170	$	4.71
Vested	(336,169)		4.86
Restricted stock at December 31, 2022	34,001	$	3.22
Vested	(34,001)		3.22
Restricted stock at December 31, 2023	—	$	—

Schedule of RSU activity

		Weighted
		Average
	Shares	Fair Value
RSUs at December 31, 2022	—	$	—
Granted	360,000		1.18
Vested	(110,000)		1.18
RSUs at December 31, 2023	250,000	$	1.18